Related Experiment Video
Updated: Jun 21, 2026
10:33
Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Anterior uveitis complicating zoledronic acid infusion
Annalisa Colucci1, Giulio Modorati, Elisabetta Miserocchi
1San Raffaele Scientific Institute, Ophthalmology, Milano, Italy. colucci.annalisa@hsr.it
Ocular Immunology and Inflammation
|August 7, 2009
Summary
Zoledronic acid effectively treats malignancy-related hypercalcemia but can rarely cause severe eye inflammation. This case highlights acute anterior uveitis as a potential side effect of zoledronic acid treatment.
Area of Science:
- Ophthalmology
- Oncology
- Pharmacology
Background:
- Zoledronic acid is a bisphosphonate commonly used to manage hypercalcemia associated with malignancy.
- While effective, bisphosphonates carry potential side effects, including rare ocular complications.
- Malignancy-related hypercalcemia requires prompt and effective treatment to improve patient outcomes.
Observation:
- A patient with breast cancer and hypercalcemia developed severe unilateral anterior uveitis 24 hours after receiving intravenous zoledronic acid.
- The patient presented with symptoms indicative of acute ocular inflammation.
- Frontal hyperostosis was noted as a comorbidity in this patient.
Findings:
- Intravenous zoledronic acid administration was temporally associated with the onset of severe anterior uveitis.
- The patient's uveitis resolved completely within one month following treatment with topical corticosteroids and cycloplegic agents.
- This case suggests a potential causal link between zoledronic acid and acute anterior uveitis.
Implications:
- Ophthalmologists and oncologists should be aware of the potential for zoledronic acid-induced uveitis.
- Early recognition and prompt treatment of ocular inflammation are crucial for favorable visual outcomes.
- Further investigation may be warranted to elucidate the mechanism of zoledronic acid-related ocular toxicity.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...